Copyright
©The Author(s) 2019.
World J Gastroenterol. Aug 28, 2019; 25(32): 4629-4660
Published online Aug 28, 2019. doi: 10.3748/wjg.v25.i32.4629
Published online Aug 28, 2019. doi: 10.3748/wjg.v25.i32.4629
Table 3 Alternative antibiotic Helicobacter pylori eradication therapy using quadruple or levofloxacin-based regimens and associated costs
Regimen | Drug | Dose | Costs(EUR) per dose | Costs (EUR) for 7 d | Costs (EUR) for 14 d |
Bismuth quadruple regimen | Tetracycline | 500 mg (four times daily) | 0.6 | 12 | 16.8 |
Metronidazole | 500 mg (three times daily) | 0.6 | 18.6 | 26.2 | |
Pantoprazole (Proton-pump inhibitor) | Standard dose (twice daily) | 0.1 | 2.2 | 3.0 | |
Bismuth Subsalicylate | Standard dose (three times daily) | 0.3 | 10.0 | 14.0 | |
In total | 1.6 | 42.8 | 60.0 | ||
Levofloxacin-based regimen | Levofloxacin | 500 mg (once daily) | 2.7 | 27.0 | 38.0 |
Amoxicillin | 1 g (twice daily) | 1.4 | 28.8 | 40.4 | |
Pantoprazole (Proton-pump inhibitor) | Standard dose (twice daily) | 0.1 | 2.2 | 3.1 | |
In total | 4.2 | 58.0 | 81.5 | ||
Concomitant regimen | Clarithromycin | 500 mg (twice daily) | 1.1 | 22.0 | 30.8 |
Amoxicillin | 1 g (twice daily) | 1.4 | 28.8 | 40.4 | |
Metronidazole | 500 mg (three times daily) | 0.6 | 2.2 | 3.0 | |
Pantoprazole (Proton-pump inhibitor) | Standard dose (twice daily) | 0.1 | 18.6 | 26.0 | |
In total | 3.2 | 72.0 | 100.0 |
- Citation: Pohl D, Keller PM, Bordier V, Wagner K. Review of current diagnostic methods and advances in Helicobacter pylori diagnostics in the era of next generation sequencing. World J Gastroenterol 2019; 25(32): 4629-4660
- URL: https://www.wjgnet.com/1007-9327/full/v25/i32/4629.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i32.4629